Mariani G, Guidi L, Barioglio A. Olanzapine versus typical neuroleptics for schizophrenia: evaluation of social and economic costs. Farmeconomia. Health Economics and Therapeutic Pathways. 2006;7(2):119-124. https://doi.org/10.7175/fe.v7i2.681